137 related articles for article (PubMed ID: 25004375)
1. Targeting the immune system in intracerebral hemorrhage.
Sheth KN; Rosand J
JAMA Neurol; 2014 Sep; 71(9):1083-4. PubMed ID: 25004375
[No Abstract] [Full Text] [Related]
2. Targeting intracerebral inflammation in multiple sclerosis: is it feasible?
Lassmann H
Acta Neuropathol; 2012 Sep; 124(3):395-6. PubMed ID: 22797580
[No Abstract] [Full Text] [Related]
3. Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study.
Fu Y; Hao J; Zhang N; Ren L; Sun N; Li YJ; Yan Y; Huang D; Yu C; Shi FD
JAMA Neurol; 2014 Sep; 71(9):1092-101. PubMed ID: 25003359
[TBL] [Abstract][Full Text] [Related]
4. Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage.
Rolland WB; Lekic T; Krafft PR; Hasegawa Y; Altay O; Hartman R; Ostrowski R; Manaenko A; Tang J; Zhang JH
Exp Neurol; 2013 Mar; 241():45-55. PubMed ID: 23261767
[TBL] [Abstract][Full Text] [Related]
5. Unlocking the constraints on memory formation.
Matheos DP; Wood MA
Nat Neurosci; 2014 Jul; 17(7):895-6. PubMed ID: 24964157
[No Abstract] [Full Text] [Related]
6. Modulation of sphingosine 1-phosphate signaling in neurologic disease.
Antel J; Hohlfeld R
Neurology; 2011 Feb; 76(8 Suppl 3):S1-2. PubMed ID: 21360856
[No Abstract] [Full Text] [Related]
7. Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice.
Lorvik KB; Bogen B; Corthay A
Blood; 2012 Mar; 119(9):2176-7. PubMed ID: 22383793
[No Abstract] [Full Text] [Related]
8. [Molecular and cellular mechanisms of fingolimod action].
Nikitin AV
Antibiot Khimioter; 2013; 58(11-12):38-42. PubMed ID: 24734428
[TBL] [Abstract][Full Text] [Related]
9. [Role of S1P acting both inside and outside the cells].
Okada T; Nakamura S
Seikagaku; 2012 Feb; 84(2):92-101. PubMed ID: 22550899
[No Abstract] [Full Text] [Related]
10. Effects of fingolimod in relapsing-remitting multiple sclerosis.
Sorensen PS
Lancet Neurol; 2014 Jun; 13(6):526-7. PubMed ID: 24685277
[No Abstract] [Full Text] [Related]
11. FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation.
Brinkmann V; Pinschewer D; Chiba K; Feng L
Trends Pharmacol Sci; 2000 Feb; 21(2):49-52. PubMed ID: 10664606
[No Abstract] [Full Text] [Related]
12. Fingolimod for multiple sclerosis.
Pelletier D; Hafler DA
N Engl J Med; 2012 Jan; 366(4):339-47. PubMed ID: 22276823
[No Abstract] [Full Text] [Related]
13. T-cell apoptosis triggered by FTY720 via mitochondrial pathway.
Fujino M; Li XK; Guo L; Kitazawa Y; Funeshima N; Fukuda S; Kimura H; Miyashita T; Okuyama T; Amano T; Suzuki S
Transplant Proc; 2001; 33(7-8):3084-5. PubMed ID: 11750325
[No Abstract] [Full Text] [Related]
14. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
Kihara A; Igarashi Y
Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
[TBL] [Abstract][Full Text] [Related]
15. Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhage.
Lu L; Barfejani AH; Qin T; Dong Q; Ayata C; Waeber C
Brain Res; 2014 Mar; 1555():89-96. PubMed ID: 24502984
[TBL] [Abstract][Full Text] [Related]
16. FTY 720.
Drugs R D; 1999 Jan; 1(1):78-80. PubMed ID: 10565994
[No Abstract] [Full Text] [Related]
17. Background and rationale for mechanism of action, efficacy, and safety of fingolimod (Gilenya), the first oral therapy for remitting-relapsing multiple sclerosis: with special emphasis upon visual safety.
Huggins A; Sergott RC
Curr Opin Ophthalmol; 2011 Nov; 22(6):447-50. PubMed ID: 21946305
[No Abstract] [Full Text] [Related]
18. New immunosuppressive reagent, FTY 720, spares immunologic memory.
Lei G; Amemiya H; Suzuki S; Goto T; Kokubo T; Miyamoto M; Kimura H
Transplant Proc; 2000 Nov; 32(7):1628. PubMed ID: 11119867
[No Abstract] [Full Text] [Related]
19. FTY720: a novel approach to the treatment of hepatic ischemia-reperfusion injury.
Anselmo D; Amersi FF; Shen XD; Gao F; Katori M; Ke B; Lassman C; Coito AJ; Brinkmann V; Busuttil RW; Kupiec-Weglinski JW; Farmer DG
Transplant Proc; 2002 Aug; 34(5):1467-8. PubMed ID: 12176443
[No Abstract] [Full Text] [Related]
20. [Lysophospholipid mediators].
Makide K; Kano K; Kitamura H; Arima N; Aoki J
Tanpakushitsu Kakusan Koso; 2009 Jan; 54(1):29-39. PubMed ID: 19195223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
